Pharmena S.A., a subsidiary of Pelion S.A., releases key information related to the results of phase 2 clinical trials for an innovative antiatherosclerotic drug 1-MNA.
PGF Urtica opens its state-of-the-art distribution centre in Łódź.
BOŚ Brokerage House recommends BUY with a target price of PLN 61 per share.
Pelion S.A. wins the statuette and title of the Icebreaker 2016 in the regional and national edition of the competition organised by the Polish Association of Employers of the Disabled.
Pelion as partner of 9th 'Innovation, Entrepreneurship and Digital Ecosystems' conference
Legg Mason Towarzystwo Funduszy Inwestycyjnych S.A. notifies that on August 25th 2016 it sold 32,064 Pelion S.A. shares, thus reducing its share in Pelion's share capital to 7.94% and its share in total vote at the Company's General Meeting to 4.85%.
For the eighth consecutive year, Pelion supports the 'Global Dignity Day' event in Poland as co-organiser and partner.
Pelion wins the Polski Kompas 2016 statuette awarded by the Gazeta Bankowa magazine.
Trigon DM S.A. recommends SELL with a target price of PLN 40 per share.
The share capital of DOZ S.A. is increased following the issue by CEPD N.V. of 3,600,000 shares with a par value of PLN 10 per share and total issue price of PLN 180m.
The 4th DOZ Forum and the 15th anniversary of the DOZ dbam o zdrowie brand
The 19th edition of the 'Urtica for Children' event
The 6th Charity Evening with Santa of the DOZ dbam o zdrowie Foundation
The 10th Edition of the RESPECT Index is announced; Pelion S.A. is included for the fifth time in the index.